Qi Zhan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- MicroRNA in disease regulation 7
- Cancer, Hypoxia, and Metabolism 7
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
Qi Zhan
53 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 345
- Biomaterials 164
- Periodontics 46
- Molecular Biology 601
- Genetics 71
Countries citing papers authored by Qi Zhan
This map shows the geographic impact of Qi Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Zhan more than expected).
Fields of papers citing papers by Qi Zhan
This network shows the impact of papers produced by Qi Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Zhan. The network helps show where Qi Zhan may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Zhan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 22 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 41 | |
| 7 | 2021 | 14 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 5 | |
| 11 | 2019 | 25 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 10 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 20 | |
| 16 | 2015 | 13 | |
| 17 | 2014 | 20 | |
| 18 | The inhibiting effect of photodynamic therapy and novel recombinant human endostatin on the n vivo growth of U251 human glioma xenografts | 2013 | 1 |
| 19 | 2006 | 73 | |
| 20 | 1995 | 1 |
About Qi Zhan
Qi Zhan is a scholar working on Cancer Research, Biomaterials, Pulmonary and Respiratory Medicine, Surfaces, Coatings and Films and Genetics, having authored 57 papers that have together received 1.1k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (12 papers), Nanoparticle-Based Drug Delivery (10 papers), Gastric Cancer Management and Outcomes (10 papers), RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (345 citations), Biomaterials (164 citations), Periodontics (46 citations), Molecular Biology (601 citations) and Genetics (71 citations). Qi Zhan has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xubo Yuan, Chunsheng Kang, Jin Zhao, Kaikai Yi, Qixue Wang, Xin Hou, Sidi Li, Hongzhao Qi, Yanli Tan and Xueping Li. Their work appears in journals such as Theranostics, Neuro-Oncology, Journal of Materials Chemistry B, Chemical Engineering Journal and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.